peresolimab
eli lilly
['peresolimab', 'imab ']
tuttle et al. phase 2 rct of peresolimab (pd-1 stimulator) in dmard-ir ra. evidence of efficacy. no new safety signals #acr22 abstr#l03 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC